menu
    • menu

    Company profile for Tenacia Biopharmaceuticals

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tenacia Biotechnology is a commercial-stage biopharmaceutical company based in Shanghai, China, dedicated to the discovery, development, and commercialization of innovative therapies for neurological disorders. Combining strong in-house R&D with global collaboration, Tenacia focuses on addressing unmet medical needs across central nervous system diseases. With an advancing pipeline and commitment to scientific rigor, Tenacia B...
    Tenacia Biotechnology is a commercial-stage biopharmaceutical company based in Shanghai, China, dedicated to the discovery, development, and commercialization of innovative therapies for neurological disorders. Combining strong in-house R&D with global collaboration, Tenacia focuses on addressing unmet medical needs across central nervous system diseases. With an advancing pipeline and commitment to scientific rigor, Tenacia Biotechnology aims to deliver differentiated treatments that improve patient outcomes and quality of life worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tenacia BiopharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    Room 3805, Wheelock Square, 1717 Nanjing West Road, Jing'an District, Shanghai...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tenacia.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insilico, Tenacia Expand AI-Driven CNS Deal to $94.75M
    Insilico, Tenacia Expand AI-Driven CNS Deal to $94.75M

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insilico-medicine-and-tenacia-biotechnology-expand-ai-driven-cns-collaboration-with-deal-value-up-to-us94-75-million-302726313.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Rapport, Tenacia Partner on RAP-219 in Greater China
    Rapport, Tenacia Partner on RAP-219 in Greater China

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251684/0/en/Rapport-Therapeutics-and-Tenacia-Biotechnology-Announce-Strategic-Collaboration-for-the-Development-and-Commercialization-of-RAP-219-in-Greater-China.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Tenacia Pens $308M Rapport Deal For China Rights To Epilepsy Med
    Tenacia Pens $308M Rapport Deal For China Rights To Epilepsy Med

    09 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tenacia-builds-308m-biobuck-deal-rapport-develop-epilepsy-drug-china

    FIERCE BIOTECH
    09 Mar 2026
    Share Share
    Tenacia Biopharma & Golden Age Partner to Commercialize ZTALMY
    Tenacia Biopharma & Golden Age Partner to Commercialize ZTALMY

    01 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-01/tenacia-biopharmaceuticals-and-golden-age-health-partner-to-commercialize-ztalmy-for-cdkl5-deficien

    PHARMIWEB
    01 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search